Multiple sclerosis (MS) affects an estimated 2.3 million people worldwide. Approximately 80% of people with MS have ...

Multiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory ...

Three decades have passed since the initial approval of disease-modifying therapies (DMTs). Ongoing discussion is focused on fundamental aspects of the disease, highlighting a growing division between ...

Tiziana (TLSA) is showing groundbreaking advancements in Alzheimer's & MS treatments with foralumab. Key trials & market ...

Shares of Tiziana Life Sciences climbed after the company said it has expanded a Phase 2 clinical trial that is underway of its treatment for multiple sclerosis, an autoimmune condition that affects ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

IMUX stock's drop appears to be an overreaction, given positive disability progression data and clean safety profile. Click ...

In this randomized controlled trial of patients with nonrelapsing secondary progressive multiple sclerosis (SPMS), oral ...

A Bournemouth couple is gearing up for a five-mile wheelchair push to raise funds and awareness for a local charity close to ...

According to Dr Asif Ahmed, an NHS GP , if you have pain, fatigue or visual problems, which worsen in hot weather, it could ...

ON THIS PAGEHome Modifications That Can HelpHome Modifications Are One Part of Care for SPMSMobility complications are often the first sign that relapsing-remitting multiple sclerosis (RRMS) is ...